Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years by MacConell L, Pencek R, Li Y, Maggs D, Porter L

Get full text

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis by Gaebler JA, Soto-Campos G, Alperin P, Cohen M, Blickensderfer A, Wintle M, Maggs D, Hoogwerf B, Han J, Pencek R, Peskin B

Get full text

A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis by Kowdley, K, Luketic, V, Chapman, R, Hirschfield, G, Poupon, R, Schramm, C, Vincent, C, Rust, C, Parés, A, Mason, A, Marschall, H, Shapiro, D, Adorini, L, Sciacca, C, Beecher-Jones, T, Böhm, O, Pencek, R, Jones, D, Obeticholic Acid Pbc Monotherapy Study Group